相关实验视频
Updated: May 12, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
6.9K
在患有刺激性肠综合征的患者中,种族和治疗偏好之间的关联
Vered Richter1,2, Efrat Broide2,3, Tzippora Shalem3
1The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
Rambam Maimonides medical journal
|April 30, 2025
概括
种族影响刺激性肠综合征 (IBS) 患者的治疗目标. 了解这些偏好,以及缓解症状,是个性化刺激性肠综合征 (IBS) 护理的关键.
科学领域:
- 胃肠病学 胃肠病学
- 医疗保健服务研究 医疗服务研究
- 医学社会学 医学社会学
背景情况:
- 刺激性肠综合征 (IBS) 是一个重大的全球健康挑战,具有多种胃肠道和肠外症状.
- 患者的治疗偏好在不同族群之间可能有所不同,因此需要对文化敏感的医疗保健方法.
- 患有IBS的阿拉伯和犹太以色列人口可能表现出不同的症状概况和治疗优先级.
研究的目的:
- 调查和比较被诊断患有刺激性肠综合征 (IBS) 的阿拉伯和犹太以色列患者的治疗目标偏好.
- 在以色列IBS患者群体中识别症状感知和治疗优先级的潜在种族差异.
- 旨在为刺激性肠综合征 (IBS) 提供量身定制和个性化的治疗策略的开发提供信息.
主要方法:
- 开发和管理双语 (希伯来语/阿拉伯语) 在线问卷,以评估治疗目标的重要性.
- 通过以色列刺激性肠综合征 (IBS) Facebook 群组和医院胃肠病诊所招募参与者.
- 在阿拉伯和犹太IBS患者队伍之间对人口统计数据,症状流行率和治疗目标偏好进行比较分析.
主要成果:
- 这项研究包括267名刺激性肠综合征 (IBS) 患者 (91名阿拉伯人,176名犹太人),犹太参与者中女性代表性更高.
- 与犹太患者相比,阿拉伯患者报告的混合型IBS,便秘,胀气,并发症和药物使用率更高.
- 两组人都优先考虑缓解腹痛,胀气和排便问题,同时认为性交困难和关节痛/肌痛不那么重要. 阿拉伯患者通常对症状管理的重要性评分较低.
结论:
- 种族背景在刺激性肠综合征 (IBS) 患者的治疗目标偏好上有显著的影响.
- 认识这些特定种族的偏好对于优化个性化刺激性肠综合征 (IBS) 管理至关重要.
- 根据患者的种族和偏好量身定制治疗方法可以提高治疗结果和患者的幸福感.
相关概念视频
Irritable Bowel Syndrome I: Introduction
207
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
207
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
241
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
241
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
98
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
98
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Irritable Bowel Syndrome III: Medical and Nursing Management
122
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
122
Chronic Bowel Disorders: Introduction
319
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
319

